Back

Notification report


Full notification file


General information

Notification Number
B/NL/21/001

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
07/01/2021

Title of the Project
MB-CART in patients with B-cell malignancies

Proposed period of release:
01/04/2020 to 30/09/2030

Name of the Institute(s) or Company(ies)
University Medical Center Groningen, Hanzeplein 1
9713 GZ Groningen
PO Box 30.001
9700 RB Groningen
The Netherlands;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
Other: mammals

Identity of the GMO:
T cells transduced with a replication-deficient lentiviral vector harbouring a chimeric antigen receptor.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HumanHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
11/02/2021 00:00:00
Remarks: